Trial Profile
A phase I study evaluating safety and efficacy of sorafenib in combination with radiation therapy in patients with unresectable liver metastases
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jan 2018
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver metastases
- Focus Adverse reactions; Therapeutic Use
- 25 Jan 2018 New trial record